Keep Us Strong WikiLeaks logo

Currently released so far... 64621 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse by classification

Community resources

courage is contagious

Viewing cable 07PARIS3399, FRENCH BIOTECH FARMERS FACE MULTIPLE PROBLEMS AND

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #07PARIS3399.
Reference ID Created Released Classification Origin
07PARIS3399 2007-08-13 15:20 2011-08-24 00:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Paris
VZCZCXRO8930
RR RUEHAG RUEHDF RUEHIK RUEHLZ RUEHROV
DE RUEHFR #3399/01 2251520
ZNR UUUUU ZZH
R 131520Z AUG 07
FM AMEMBASSY PARIS
TO RUEHC/SECSTATE WASHDC 9470
RUEHRC/USDA FAS WASHDC
INFO RUCNMEM/EU MEMBER STATES
RUEHMRE/AMCONSUL MARSEILLE 1864
RUEHSR/AMCONSUL STRASBOURG 0465
RUEHGV/USMISSION GENEVA 2722
RHEHAAA/WHITE HOUSE WASHDC
UNCLAS SECTION 01 OF 03 PARIS 003399 
 
SIPDIS 
 
SENSITIVE 
SIPDIS 
 
BRUSSELS PASS USEU FOR AGMINCOUNSELOR 
STATE FOR OES; EUR/ERA AND EB(SPIRNAK); 
STATE PASS USTR FOR MURPHY; 
USDA/OS/JOHANNS/TERPSTRA; 
USDA/FAS FOR OA/YOST; 
OCRA/CURTIS 
STA/SIMMONS/JONES/HENNEY 
FAA/YOUNG; 
EU POSTS PASS TO AGRICULTURE AND ECON 
GENEVA FOR USTR, ALSO AGRICULTURE 
 
E.O. 12958: N/A 
TAGS: EAGR ETRD EU FR
SUBJECT: FRENCH BIOTECH FARMERS FACE MULTIPLE PROBLEMS AND 
CHALLENGES 
 
REF:  Paris 1448 
 
PARIS 00003399  001.2 OF 003 
 
 
1. Summary.  French biotech farmers are facing multiple challenges 
as they expand biotech corn acreage four fold in 2007.  Despite this 
increase, talk of a biotech moratorium during the presidential 
campaign and new reporting requirements chilled what was expected to 
be an even larger amount following a successful 2006 biotech 
harvest.  Even though farmers have surged ahead with production, 
while only having one biotech variety (Mon810) available for 
cultivation and only one market (Spain) in which to sell, 
anti-biotech activists continue their highly visible and detrimental 
campaign to destroy acceptance of biotechnology in France; acts 
aimed to discourage production by the farmers; to raise tensions 
between conventional and biotech farmers; to denigrate the image of 
biotech products in the minds of consumers and to sway the opinion 
of policy makers.  The French government has failed to provide a 
regulatory structure or public support for the farmers, adding to 
the stress and uncertainty they face in producing a biotech crop. 
End Summary. 
 
Background 
---------- 
2.  France is the largest corn producer in the European Union, with 
1.4 million hectares planted, producing 12 million tons in 2006 and 
exporting 5 million tons, primarily to Spain, the Netherlands, the 
United Kingdom and Germany.  The French Ministry of Agriculture 
reports that French farmers planted more than 21,000 hectares of 
MON810 GM in 2007, representing roughly 0.75 percent of total French 
corn acreage.  Officials with the French Corn Growers Association 
(AGPM) also believe that several thousand hectares (less than 3,000) 
have been planted, but not reported, by farmers in the northern half 
of France for on-farm usage.  The 2007 biotech corn acreage 
represents a four-fold increase from 2006.  While analysts had 
initially forecast 2007 biotech acreage of up to 50,000 hectares, 
experts now believe that farmers' spring planting decisions were 
negatively influenced by the anti-biotech positions of several 
leading presidential candidates and the new requirement that biotech 
field locations, which must be made to the Ministry of Agriculture, 
be made public. 
 
3.  Even though French farmers only have access to one type of 
biotech seed, Mon810, patented by Monsanto, this variety is very 
helpful in capturing the maximum returns from their crop. Financial 
analysis by AGPM showed that extra profit from Mon810 crop, 
resulting from higher yields, higher crop quality and lower input 
costs offset fourfold the increased seed cost.  Mon810 plants 
produce their own insect resistance making them less vulnerable to 
attacks by the European corn borer (Ostrinia nubilalis), an insect 
that thrives in southern France.  Its larvae (caterpillar) eats the 
leaves and bores into the plant stalk, causing it to produce fewer 
and lower quality kernels and weakening it against negative weather 
impacts such as strong winds.  Mon810 corn plants need fewer 
pesticide applications and produce a higher quality product with 
fewer input costs than traditional corn. 
 
4.  While Monsanto has the only patent available for biotech 
cultivation in France, other seed companies, having purchased a 
license from Monsanto, are now providing French farmers with more 
biotech seed selection. 
 
Markets 
------- 
 
5.  The primary biotech product found in France is soybean meal, 
imported mainly from South America, which is used (98%) in the 
manufacture of animal feed.  French consumers seem to be unaware 
that the animal products available on the French market may well 
have originated from an animal nourished on biotech feed.  On the 
other hand, French consumers are very aware of, and continue to 
resist, the utilization of biotech in other products destined for 
human consumption.  Since there is no market for biotech corn in the 
French food industry, biotech corn produced in France is primarily 
exported to Spain for use in animal feed. 
 
 
PARIS 00003399  002.2 OF 003 
 
 
6.  Spain is currently the only commercial market for French biotech 
corn.  The product is shipped to Spain mainly in trucks.  Keeping 
biotech corn separated from conventional corn in storage and/or 
transportation has not proven to be a problem in the past, with the 
caveat that as the GM crop gets bigger, more adventitious 
contamination may happen.  AGPM officials are confident that having 
the Spanish market as the only outlet for biotech corn will not 
prove to be a limiting factor as demand remains strong. 
 
7.  In addition, demand for biotech corn is expected to increase as 
farmers expand their on-farm usage for animal feed.  Interestingly, 
even though French feed manufacturers buy domestically-grown corn, 
primarily for use in pork and poultry feed, they refuse to purchase 
biotech corn.  AGPM officials intend to pursue domestic feed 
manufacturers as another potential lucrative market. 
 
8.  AGPM officials hope to convince French feed manufacturers that, 
with mycotoxin levels significantly lower than in conventional corn, 
biotech corn should be an attractive commodity for their product. 
Mycotoxins are toxic by-products of various fungi, mainly of the 
Aspergillum or Fusarium families.  Corn plants experiencing stress 
from conditions such as insect damage, drought or heat, may be more 
prone to fungi infestation, and therefore, will have increased 
levels of mycotoxins.  Mycotoxins can have serious health impacts on 
animals and humans when ingested, some are even suspected of being 
carcinogenic.  Thus, the Mon810 biotech corn grown in France, which 
contains an insect resistant component, produces corn with less 
stress, lower levels of mycotoxins and produces a safer animal feed 
product. AGPM conducted studies showing that, in 2006, Mon810 corn 
produced in France had mycotoxins contents more than 2000 time lower 
than non-GM corn.  This will be important for farmers whose corn 
must meet lower EU maximum mycotoxin levels beginning in October 
2007. 
 
Problems:  Anti-Biotech Activities 
---------------------------------- 
 
9.  While French biotech farmers can feel secure, for now, in their 
ability to market their product, they face several other 
discomforting factors.  In France, lack of consumer acceptance of 
agricultural biotechnology in products for human consumption 
continues to be very strong.  Food products labeled as containing or 
derived from biotech are generally not available on the French 
market. 
 
10. Anti-biotech activists (mainly Greenpeace, Faucheurs 
Volontaires, ATTAC, Friends of the Earth, CRI-GEN and Confederation 
Paysanne farmers union) are well organized, highly visible and work 
consistently to discourage progress for biotech acceptance.  During 
the summer of 2006, activists destroyed two thirds of the open-field 
test plots.  Farm groups fumed at the immunity that anti-biotech 
groups have been afforded in these acts of destruction. 
 
11. This summer, activists, dedicated to continuing their 
destructions in as public a manner as possible, have been busy with 
a variety of sabotage tactics, including, spreading traditional corn 
pollen on a GMO corn field; possibly spreading chemicals which 
prevented pollination; capturing bees in an GMO field to prevent 
them from pollinating the corn plants; pulling up corn plants; and 
assembling on farmers fields to convince them to destroy their GMO 
corn (even if for on-farm feed). 
 
12. The last tactic received wide media coverage after a biotech 
farmer hanged himself before a planned anti-OGM rally near his field 
on August 5th.  Although other factors may have contributed, 
following this incident, the French Minister of Ecology and the 
Minister of Agriculture issued a joint statement reiterating that 
the farmer was within his legal rights, that the State would not 
tolerate any forms of violence and asked that everyone respect the 
rule of law.  FNSEA, the largest farmers union in France, usually 
quiet on the biotech issue, publicly decried the fact that biotech 
farmers are growing their crops under almost clandestine 
circumstances to avoid being targeted. 
 
 
PARIS 00003399  003.2 OF 003 
 
 
13.  Biotech farmers are also facing attacks from traditional 
farmers.  A beekeeper is alleging that pollen from a biotech corn 
field has ruined his honey harvest and is suing the biotech farmer 
for damages. 
 
14.  Less visible to the public, but still very effective, is the 
pressure imposed by anti-biotech groups on the feed and food 
industries.  For example, the Greenpeace website has a "blacklist" 
containing the name of any biotech food product marketed in France. 
Experience has shown that the negative publicity generated by 
offering a biotech product in a French supermarket is usually so 
detrimental that the retailer or distributor removes the product 
from the shelf. 
 
French Government Reactions 
--------------------------- 
 
15.  (SBU) French biotech farmers have found little governmental 
support for their efforts.  Nathalie Kosciusco-Morizet, the new 
Minister of State for Ecology, advocates a strong precautionary 
approach and only supports biotech research.  French Minister of 
Agriculture Michel Barnier, according to high-level contacts at the 
Ministry, holds a more conservative view of agricultural 
biotechnology than his predecessor. (Mr. Barnier formerly served as 
a French Minister of the Environment.)  However, he has promised to 
keep a fair and unbiased position toward biotechnology in his 
official functions. 
 
16.  Nevertheless, support by the Ministry of Agriculture has been 
less than robust.  The Ministry has, so far, limited its objections 
to the crop destructions to press releases.  The Ministry did 
publish "guidelines" in spring 2007 for planting measures between 
conventional and biotech corn.  But farmers have no official 
regulations with which to comply leaving them vulnerable to 
liability from neighboring conventional farmers.  (Reftel 1448) 
Additionally, the Ministry imposed a new requirement for 2007 that 
farmers must report their biotech acreage and location, by district, 
to a national register maintained by the Ministry (and available 
online). The Ministry suggested that farmers voluntarily notify 
their neighbors growing conventional corn.  Even though the Ministry 
registry does not provide the precise location of biotech crops, 
anti-biotech activists have honed in on two primary production areas 
and published a list of the biotech field locations. 
 
17.  Farmers are also frustrated that the police, in general, 
observe and tolerate the crop destructions, and the judicial system 
metes out moderate punishment to the activists who are prosecuted. 
In one case, the activists were found not guilty by reason of 
necessity, basically allowing them a self-defense argument that 
biotech development could be harmful to public health.  The French 
legislature has also failed to pass any substantive measures on 
behalf of the biotech farmers. 
 
18.  French authorities remain reticent to permit new biotech 
varieties for cultivation, abstaining on two recent EU votes for new 
biotech products.  French authorities confirmed that France will not 
support any new biotech measures before a government sponsored 
environmental conference to be held in October in Paris. 
 
19. AGPM, French farm groups and Post will be closely following this 
environmental conference known as the "Le Grenelle de 
l'Environnement."  Farmers' representatives as well as anti-biotech 
organizations are participating in preliminary meetings leading up 
to the conference. 
 
Pekala